Fundraising FoxACCELERATOR LIFE SCIENCE PARTNERS — Full Portfolio
4 tracked investments · listed companies and verified rows first
Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation.
AI & Machine LearningBiotechDeep Tech
Zian-Loong Wang(Chief Technology Officer & Co-Founder)Michael Lazarou(Co-Founder)inThong Q. Le(Chief Executive Officer)in
Co-investorsClavystBioXora Innovation Pte Ltd
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for substance use disorders and specialty central nervous system (CNS) conditions, including treatments for opioid withdrawal and seizure disorders.
BiotechHealthtechSeattle, US
CHRISTOPHER TOOMBS(Executive Officer)inLINDSAY RAYLE(Executive Officer, Promoter)M. Johnston Erwin(Director)David Schubert(Executive Officer, Promoter)
BoardSTEVEN GILLIS(Director)inThong Le(Executive Officer, Director, Promoter)
Co-investorsAlexandriaARCH Venture PartnersWRF Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.